button bars forest bayes pooled summary circles
 
deaths (OS)

Extensive stage SCLC (Es-SCLC) - 1st Line (L1) Extensive stage SCLC (Es-SCLC) Extensive stage SCLC (Es-SCLC) - 1st Line (L1)

versus placebo plus SoC
atezolizumab plus SoC vs. placebo plus SoC 1 0.70 [0.54; 0.91], 1 RCT, I2=0% conclusive
unassessable degree of certainty

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons